05:00 PM EDT, 10/29/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) reported a Q3 loss late Wednesday of $0.95 per diluted share, versus a $0.86 loss a year earlier.

Analysts polled by FactSet expected a loss of $0.89.

Net sales for the quarter ended Sept. 30 were $120.7 million, up from $2.73 million a year earlier.

Analysts surveyed by FactSet expected $106.4 million.

Shares of the company traded 6.2% lower in after-hours activity.